Connective Tissue Disease
Botulinum toxin reduces pain, disability in Raynaud’s syndrome secondary to scleroderma
Botulinum toxin injections in the hand led to significant reductions in pain and disability for patients with Raynaud’s syndrome secondary to scleroderma, according to data published in Clinical Rheumatology.
FDA grants 510(k) clearance to Werfen’s reagent for connective tissue disease testing
The FDA has granted 510(k) clearance to Werfen for its Aptiva Connective Tissue Disease Essential reagent to assist in the diagnosis of patients with autoimmune diseases, according to a manufacturer press release.
New autoantibody analysis may improve early connective tissue disease diagnoses
A novel, fully automated multiparametric autoantibody analysis may improve the early diagnosis of connective tissue diseases, particularly lupus and Sjögren’s syndrome, according to data published in Arthritis Research & Therapy.
Rituximab ‘should be considered’ an alternative to cyclophosphamide in CTD-ILD
PHILADELPHIA — Rituximab is comparable in terms of safety and efficacy to cyclophosphamide among patients with interstitial lung disease associated with connective tissue diseases, according to data presented at ACR Convergence 2022.
Collaboration with pulmonology key to managing ILD in autoimmune disease
SAN DIEGO — A clear intervention plan and collaboration with pulmonology are key to managing patients with interstitial lung disease in autoimmune conditions, according to a speaker at the Congress of Clinical Rheumatology West.
‘Muddled field’ of hypermobility leaves patients with unaddressed, misunderstood pain
SAN DIEGO — The broad spectrum of hypermobility and connective tissue disorders has proven difficult to define and categorize, leaving many patients in pain, according to a speaker at the Congress of Clinical Rheumatology West.
Selexipag improves outcomes in PAH-associated connective tissue disease in real-world study
SAN FRANCISCO — New real-world data demonstrate treatment with selexipag improved outcomes in patients with pulmonary arterial hypertension associated with connective tissue disease.
Top in rheumatology: Aquatic exercise for back pain, RCTs on connective tissue disease
A recent study found that patients with chronic lower back pain who underwent therapeutic aquatic exercise saw greater improvements than those who underwent physical therapy. It was the top story in rheumatology last week.
'Waste of energy': One-third of connective tissue disease RCTs never completed, published
One out of three registered randomized controlled trials on connective tissue diseases are never completed or published, representing a “waste of energy or resources” that may skew meta-analyses, according to researchers.
GI, cardiovascular, autonomic, allergic symptoms more prevalent in Ehlers-Danlos syndrome
Patients with Ehlers-Danlos syndrome experience significantly more prevalent gastrointestinal, cardiovascular, autonomic and allergic symptoms than those in the hospital without the disease, according to data published in Rheumatology.